Skip to main content
Download PDF

HIV late presentation and advanced HIV disease among patients with newly diagnosed HIV/AIDS in Southwestern China: a large-scale cross-sectional study

AIDS Research and Therapy volume 16, Article number: 6 (2019) Cite this article

Abstract

Objective

This study aimed to investigate the prevalence of HIV late presentation and advanced HIV disease and to identify the factors associated with HIV late presentation and advanced HIV disease among patients with newly diagnosed HIV/AIDS in the Guangxi Zhuang Autonomous Region, in Southwestern China.

Methods

Patients with newly diagnosed HIV registered in the HIV surveillance system of Guangxi Centers for Disease Control between January 2012 and December 2016 were included in this study.

Results

Of 45,118 newly diagnosed patients, 70.2% had late presentation, and 45.1% had advanced HIV disease. A higher prevalence of late presentation and advanced HIV disease was found in male heterosexuals and female people who use drugs (PWID). Heterosexuals (OR 2.11 [95% CI 1.90–2.34]) and PWID (OR 1.55 [95% CI 1.30–1.84]) had a higher risk of late presentation than men who have sex with men (MSM). Blood testing of the blood receivers (OR 1.75 [95% CI 1.36–2.26]) and diagnosed in hospital (OR 1.74 [95% CI 1.65–1.84]) had an increased risk of late presentation compared to those who diagnosis in voluntary counseling and testing (VCT). Heterosexuals (OR 2.86 [95% CI 2.51–3.27]), PWID (OR 2.23 [95% CI 1.83–2.71]), blood testing of the blood receivers (OR 1.58 [95% CI 1.29–1.94]) and diagnosed in hospital (OR 1.85 [95% CI 1.76–1.94]) were also independent risk factors associated with advanced HIV disease. Older age, lower level of education and being divorced or widowed were also associated with late presentation and advanced HIV disease.

Conclusions

Late presentation and advanced HIV disease were very common among patients with newly diagnosed HIV in Guangxi, China during 2012–2016. Targeted programs are urgently required to reduce HIV late diagnosis in Guangxi, especially for male heterosexuals, PWID, and patients with characteristics such as older age, lower level of education, divorced or widowed.

Introduction

The number of people living with human immunodeficient virus/acquired immune deficiency syndrome (HIV/AIDS) has steadily increased worldwide and reached 36.9 million in 2017 [1]. In China, by the end of 2017, a cumulative total of 758,000 individuals were reported to be HIV infected, with more than 100,000 HIV-positive patients reported in the Guangxi Zhuang Autonomous Region [2]. To effectively control the global HIV/AIDS epidemic, the Joint United Nations Programme on HIV/AIDS (UNAIDS) put forward a 90–90–90 target in 2013, aiming to 90% of people living with HIV aware about their status, treat 90% of these detected cases with antiretroviral therapy (ART), and achieve viral load suppression in 90% of those receiving treatment by 2020 [3]. However, at present, only 60% of people with HIV infection are aware of their infectious status worldwide [1], which, to a great degree, stands in the way of achieving the 90–90–90 target.

Timely initiation of ART has been considered as one of the most effective approaches to reduce the risk of HIV transmission. Early diagnosis of HIV is a crucial step to achieve the goal of early treatment [4,5,6]. Nevertheless, almost half of HIV-positive patients are late diagnosed worldwide [7]. In Europe, more than one-third of patients with HIV/AIDS are late diagnosis, resulting in delayed treatment [8]. In China, a study conducted at the national level showed that 58.8% of patients with newly diagnosed HIV from 2006 to 2012 were late diagnosed [9]. Another study indicated that the rate of advanced HIV disease in China ranged from 35.5% to 42.1% during 2010–2014 [10]. Compared with those with early diagnosis, the patients with late diagnosis were worse in terms of immune system at diagnosis [11, 12], and paid a higher cost for the therapy [13]. Moreover, late diagnosed cases may cause inadvertent HIV transmission before they are aware of their HIV infection status [14]. More importantly, late diagnosis is always associated with higher mortality and morbidity due to various opportunistic infections, especially tuberculosis, invasive bacterial, and fungal infections [15]. A retrospective study revealed that among patients with advanced HIV disease, 57% had opportunistic infections and the majority of them were diagnosed when they developed AIDS-defined illness [16].

The Guangxi Zhuang Autonomous Region, a province in western China, has the second highest HIV-infected reported cases in China, accounting for ~ 13% of total national HIV/AIDS cases. Even worse, the mortality among patients with HIV/AIDS in that region reached up to 34.9% by the end of 2017, which is far higher than the average of national level (24.0%). Late diagnosis is one of the important predictors of HIV/AIDS-related mortality [17]. However, information about HIV late diagnosis in Guangxi, in addition to the influencing factors, should be further explored. To date, only a few studies reported the situation in a county or a city in Guangxi [18]. In addition, even in other cities of mainland China, only a small number of studies have identified the factors associated with late HIV diagnosis in several cities [19,20,21,22]. Reducing HIV/AIDS epidemic is extremely urgent for Guangxi through some effective targeted prevention strategies. Therefore, the present study investigated the situation of late presentation (CD4 < 350/mm3, or AIDS-defining event regardless of CD4 count) and advanced HIV disease (CD4 < 200/mm3, or AIDS-defining event regardless of CD4 count) among patients with newly diagnosed HIV/AIDS. Also, the influencing factors, including demographic or socioeconomic variables associated with late presentation and advanced HIV disease, were analyzed.

Methods

Study population

All patients with newly diagnosed HIV/AIDS who registered in the HIV surveillance system of Guangxi Centers for Disease Control (CDC) between January 2012 and December 2016 were included in this study. The inclusion criteria were as follow: (1) HIV positive, (2) aged at least 15 years, (3) had a CD4+ T-cell count during diagnosis (it was defined as the first CD4+ T-cell count detection within 3 months after diagnosis), (4) were ART-naïve when the first CD4+ T-cell count was detected. This study excluded HIV-1 infected patients who had no record of CD4+ T-cell count, had the first CD4+ T-cell count detection longer than 3 months after diagnosis, and were on ART before the CD4+ T-cell count was detected.

Study design

A cross-sectional study was conducted to investigate the prevalence of late presentation and advanced HIV disease among patients with newly diagnosed HIV/AIDS and the influencing factors associated with late presentation and advanced HIV disease. Demographic or socioeconomic data, including gender, age, region, marital status, occupation, ethnic, educational attainment, and HIV transmission route, as well as clinical data, such as CD4+ T-cell count at diagnosis, year of HIV diagnosis, and reason for HIV testing, were collected from the records of HIV surveillance system and used for subsequent analyses.

Definitions

CD4+ T-cell counts were determined by flow cytometry. According to a consensus definition as presented by the European Late Presenter Consensus working group [23], late presentation was defined as, a patient diagnosed with the first CD4+ T-cell count < 350/mm3, or a patient with a AIDS-defining illness regardless of CD4+ T-cell count during diagnosis. Besides, advanced HIV disease was defined as a patient with a CD4+ T-cell count < 200/mm3, or a patient with an AIDS-defining illness regardless of CD4+ T-cell count during diagnosis.

Statistical analysis

The trends of late presentation and advanced HIV disease were analyzed using the Chi square test. The risk factors associated with late presentation and advanced HIV disease were analyzed by univariate and multivariate logistic regression analyses. The univariate analysis explored variables (attributes) one by one. Variables could be either categorical or numerical. The multivariate analysis was based on the statistical principle of multivariate statistics, which involved observation and analysis of more than one statistical outcome variable at a time. A P-value less than 0.05 was considered statistically significant. Statistical analyses were performed using the SPSS16.0 software (IBM, NY, USA).

Results

Characteristics of late presentation and advanced HIV disease

A total of 47,801 patients with newly diagnosed HIV registered in the HIV surveillance system of Guangxi CDC between 2012 and 2016. Among them, 45,118 patients met the inclusion criteria with no missing data regarding the CD4+ T-cell count in 3 months after diagnosis and those aged 15 years or older during diagnosis (Fig. 1). Their characteristics are summarized in Table 1. The overall median CD4+ T-cell count was 228/mm3 [interquartile range (IQR): 78–383]. In the study population, 70.2% (31,663/45,118) were diagnosed with late presentation with a mean age of 49.8 years, and 45.0% (20,325/45,118) were diagnosed with advanced HIV disease with a mean age of 50.3 years (Table 1). Higher percentages of late presentation and advanced HIV disease were found in men (late presentation/advanced HIV disease: 73.6%/77.6%), those aged more than 50 years (late presentation/advanced HIV disease: 48.9%/49.3%), migrant workers (late presentation/advanced HIV disease: 77.5%/79.5%), married (late presentation/advanced HIV disease: 62.2%/61.0%), Han ethnicity (late presentation/advanced HIV disease: 62.6%/63.5%), primary/no education (late presentation/advanced HIV disease: 88.7%/90.0%), transmission by heterosexual sex (late presentation/advanced HIV disease: 94.9%/96.1%), and those diagnosed in hospital (late presentation/advanced HIV disease: 45.1%/52.3%) (Table 1).

Fig. 1
figure 1

Chart of the inclusion and exclusion criteria in this study

Full size image
Table 1 The demographic and sociological features of the patients
Full size table

Percentages of late presentation and advanced HIV disease by the transmission group and gender

Percentages of late presentation and advanced HIV disease by the main transmission group and gender are shown in Fig. 2. Overall, compared with the groups of heterosexuals and people who use drugs (PWID), the men who have sex with men (MSM) group showed the lowest percentages of late presentation and advanced HIV disease (late presentation: 49.9%; advanced HIV disease: 18.8%). The highest percentages of late presentation and advanced HIV disease were found in male heterosexuals (late presentation: 75.0%; advanced HIV disease: 51.7%). Among PWID, women had higher percentages of late presentation and advanced HIV disease (late presentation: 61.2%; advanced HIV disease: 37.3%) compared with men (late presentation: 55.1%; advanced HIV disease: 31.9%) (Fig. 2).

Fig. 2
figure 2

Percentages of HIV late presentation and advanced HIV disease for 2012–2016, by transmission groups (MSM men who have sex with men, PWID people who use drugs) and gender

Full size image

Trends of late presentation and advanced HIV disease

The trends of late presentation and advanced HIV disease during 2012–2016 by transmission groups (MSM, heterosexual, and PWID) are presented in Fig. 3. Overall, the percentage of patients with late presentation or advanced HIV disease was relatively stable over time. No significant difference was found in the trend test (late presentation: χ2 = 3.14, P = 0.07; advanced HIV disease: χ2 = 0.92, P = 0.34) (Fig. 3a). The trend analysis of late presentation or advanced HIV disease by main transmission groups (MSM, heterosexual and PWID) yielded similar results (no significant difference, P > 0.05) (Fig. 3b).

Fig. 3
figure 3

Changes of late presentation and advanced HIV disease by year of diagnosis (a) and transmission groups (MSM men who have sex with men, PWID people who use drugs) (b)

Full size image

Factors associated with late presentation

As shown in Table 2, in a univariate analysis, patients with late presentation were significantly associated with male sex, older age, migrant workers, divorced or widowed, primary/no education,  blood testing of blood receivers and diagnosed with HIV in hospital and STI clinics. These variables were further included in the multivariate analysis (Table 2), Which showed that late presentation significantly increased with age during diagnosis [adjusted odds ratio (aOR; 95% confidence interval (CI) for 30–50 years old vs. 15–30 years old: 1.68 (1.58–1.79); > 50 years old vs. < 15–30 years old: 1.97 (1.85–2.11)]. Men had a stronger association with the probability of late presentation [aOR: 1.43; 95% CI (1.36–1.50)]. Patients transmitted by heterosexual sex [aOR: 2.11; 95% CI (1.90–2.34)], PWID [aOR: 1.55; 95% CI (1.30–1.84)], or other transmissions including contaminated blood transfusion [aOR: 2.22; 95% CI (1.67–2.95)], had a higher risk of late presentation compared with MSM. Hospital and blood testing of the blood receivers had an increased risk of late presentation compared with voluntary counseling and testing (VCT), with an aOR of 1.74 (95% CI 1.65–1.84) and 1.75 (95% CI 1.36–2.26) respectively. Patients who were diagnosed HIV for medical examination [aOR: 0.47; 95% CI (0.35–0.63)], penitentiary [aOR: 0.52; 95% CI (0.45–0.59)], or premarital/pregnancy screening [aOR: 0.63; 95% CI (0.58–0.69)], had a significantly greater probability for early diagnosis (Table 2).

Table 2 Risk factors associated with late presentation (logistic regression model), Guangxi, 2012–2016
Full size table

Factors associated with advanced HIV disease

As shown in Table 3, in a univariate analysis, patients with advanced HIV disease were significantly associated with male sex, older age, migrant workers, divorced or widowed, primary/no education, blood testing of blood receivers and diagnosed HIV in hospital and STI clinics. These variables were further included in the multivariate analysis (Table 3). The results showed that the patients aged 31 to 50 years [aOR: 1.68; 95% CI (1.56–1.80)], and those aged older than 50 years [aOR: 1.51; 95% CI (1.40–1.62)], had a higher occurrence of advanced HIV disease compared with those aged 15 to 30 years. Compared with female patients, male patients had a higher aOR of advanced HIV disease [aOR: 1.66; 95% CI (1.58–1.74)]. Compared with MSM, all other HIV transmission groups were more likely to be associated with advanced HIV disease, especially in PWID [(aOR 2.23; 95% CI (1.83–2.71)] and in heterosexuals [(aOR 2.86; 95% CI (2.51–3.27)]. Tested HIV in hospital [aOR: 1.85; 95% CI (1.76–1.94)] was found to be an independent relative factor for advanced HIV disease among the factors for HIV testing. Advanced HIV disease was also more common in blood testing of the blood receivers (aOR 1.58, CI 1.29 to 1.94). In addition, diagnosed HIV for premarital/pregnancy screening [aOR: 0.36; 95% CI (0.33–0.41)], medical examination [aOR: 0.39; 95% CI (0.27–0.56)], penitentiary [aOR: 0.37; 95% CI (0.32–0.44)], HIV-positive couple or partner [aOR: 0.65; 95% CI (0.59–0.72)], and pre-surgery [aOR: 0.83; 95% CI (0.77–0.90)] were protective factors for the occurrence of advanced HIV disease.

Table 3 Risk factors associated with advanced HIV disease (logistic regression model), Guangxi, 2012–2016
Full size table

Discussion

This novel study investigated the prevalence of late presentation and advanced HIV disease in Southwestern China. One strength of this study was its large sample size. Further, the completeness of the data was high, because more than 94% of the newly diagnosed patients were included in this study, and also the important information, including CD4 T-cell counts during diagnosis or the first entry into care and AIDS-defining illnesses, was available.

The study showed that the local prevalence of late presentation reached up to ~ 70% in recent years, indicating that late diagnosis is a serious problem in Guangxi, China The prevalence of late presentation in Guangxi not only is higher than those in other countries [24, 25], but also higher than those in other regions in China, including Zhejiang province [26] and Guangzhou City [27]. Besides, the prevalence of advanced HIV disease in Guangxi is higher compared with national level in China (42.1% vs. 35.5%) [10]. Late presentation is associated with an increased rate of AIDS/deaths, particularly in the first year after HIV diagnosis [23]. Therefore, a high prevalence of late presentation and advanced HIV disease may be an important factor for the high mortality among patients with HIV/AIDS in Guangxi. Reducing late HIV diagnosis and advanced HIV disease is considered a public health priority and continues to be a great challenge in most countries [28, 29]. To achieve this goal, the US CDC and the US Preventive Services Task Force newly recommended one-time HIV testing for persons aged 15–65 years as part of routine health care [30, 31].

This study revealed that men were associated with late presentation, which was consistent with the results of previous studies. A meta-analysis which including 32 studies, revealed that the pooled aOR of men with advanced HIV disease and late presentation compared with women was 1.73 and 1.38, respectively [32]. One possible reason was that HIV-infected women generally experienced a slower disease development compared with men, which was corroborated by the fact that women tended to have higher CD4+ lymphocyte counts compare with men with similar infection time [33]. Nevertheless, two other studies from Belgium and North-East Scotland [34, 35] suggested that women were more likely diagnosed late. This discrepancy might be contributed to the fear of stigma and discrimination, being a significant issue particularly among women in certain areas in the world.

Older age was also found to be a factor associated with late presentation in this study, which was similar to the results of other previous studies [36, 37]. This might be due to several reasons. The HIV symptoms in older people were misjudged as other illnesses for being older [38, 39], or the elderly were hard to be a target of HIV prevention efforts [40]. Psychological factors, such as depression, associated with delayed diagnosis and late testing [41], are more common in older adults, which may also hinder access to health care [42]. The study indicated that older age was also associated with advanced HIV disease, which was different from the findings of some similar studies [43,44,45].

In this study, PWID and heterosexuals were more likely to be associated with late presentation and advanced HIV disease compared with MSM. The reason, possibly, was that the access or barriers of HIV testing for different risk populations might be different. Most of PWID were reluctance to access the health care system, while they were asymptomatic [46, 47]. However, MSMs were more likely to have an HIV testing due to various encouragement strategies, such as opt-out HIV testing (tests are routinely offered to all patients) at STI clinics and the encouragement of high-risk MSMs for HIV testing every 6 months [48]. For heterosexuals, effective HIV testing strategies are lacking. Hence, a more forward-looking proposal of HIV testing in different health care settings is urgently needed to reduce the high rates of late diagnosis.

Diagnosed HIV in hospital and those that had HIV testing before accepting blood transfusion were two relatively strong factors associated with late presentation and advanced HIV disease, suggesting that patients didn’t visit a doctor until the clinical symptoms appeared and treatment was initiated at a later disease stage. The other possible explanations could be that the clinical manifestations lack specificity, contributing to the missed diagnosis of HIV infection by health care professionals. Health care professionals should play an important role in recommending HIV testing in the presence of AIDS defining diseases as well as for the specific HIV indicator conditions [49]. On the contrary, the higher CD4 lymphocyte count at presentation was found among patients with an HIV-positive partner or those who were diagnosed by premarital/pregnancy screening, medical examination, penitentiary, pre-surgery and VCT, indicating that routine HIV testing is an effective measure to reduce late diagnosis. A recent report has shown that the lack of routine HIV testing is a general health challenge, associated with a poor medical level in rural areas [50]. Hence, efforts should be made to detect patients with HIV/AIDS promptly.

This study had several limitations. First, participants of this study were from one province of China, thus leading to a selection bias. Nevertheless, the large sample size and multicenter study in essence (the subjects came from all counties and cities across Guangxi province) could partially reduce the bias. Second, the details of the category of AIDS defining illness were unavailable. Third, variables used in this study were somewhat limited because this study was actually a retrospective cross-sectional investigation, and some influencing factors might have been missed. Further study focusing on the association of knowledge, attitude, and practice of patients toward HIV/AIDS and the clinical symptoms of patients with late diagnosis, should be conducted to better identify the influencing factors and control late diagnosis.

Conclusions

In conclusion, late diagnosis was quite common among patients with newly diagnosed HIV/AIDS in Guangxi, China, during 2012–2016, which is a challenge for the prevention and control of HIV/AIDS. Given the fact that late diagnosis in Guangxi has not shown a decreasing trend in recent years, targeted programs should be urgently designed to reduce HIV late diagnosis.

Abbreviations

UNAIDS:

the Joint United Nations Programme on HIV/AIDS

ART:

antiretroviral therapy

HIV:

human immunodeficiency virus

AIDS:

acquired immune deficiency syndrome

MSM:

men who have sex with men

PWID:

people who use drug

CDC:

Centers for Disease Control

VCT:

voluntary counseling and testing

IQR:

interquartile range

aOR:

adjusted odds ratio

STI:

sexually transmitted infection

References

  1. UNAIDS. Global HIV & AIDS statistics—2018 fact sheet. Geneva: UNAIDS; 2018. http://www.unaids.org/en/resources/fact-sheet

  2. Chinese Journal of STD & AIDS. The National AIDS and STD Epidemic in December 2017. Beijing: Chinese Journal of STD & AIDS; 2018(02):111.

  3. Friedland G. Marking time in the global HIV/AIDS pandemic. JAMA. 2016;316(2):145–6.

    Article  Google Scholar 

  4. Marks G, et al. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr. 2005;39(4):446–53.

    Article  Google Scholar 

  5. Liu P, et al. Early antiretroviral therapy on reducing HIV transmission in China: strengths, weaknesses and next focus of the program. Sci Rep. 2018;8(1):3431.

    Article  Google Scholar 

  6. Cohen MS, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.

    Article  CAS  Google Scholar 

  7. Lazarus JV, et al. The case for indicator condition-guided HIV screening. HIV Med. 2013;14(7):445–8.

    Article  CAS  Google Scholar 

  8. Miranda AC, et al. Evolution trends over three decades of HIV infection late diagnosis: the experience of a Portuguese cohort of 705 HIV-infected patients. J Int AIDS Soc. 2014;17(4 Suppl 3):19688.

    Article  Google Scholar 

  9. Tang H, et al. Baseline CD4 cell counts of newly diagnosed HIV cases in China: 2006–2012. PLoS ONE. 2014;9(6):e96098.

    Article  Google Scholar 

  10. Jin X, et al. Analysis on the ‘ late diagnosis’ (LD) phenomena among newly identified HIV/AIDS cases in China, 2010–2014. Zhonghua Liu Xing Bing Xue Za Zhi. 2016;37(2):218–21.

    CAS  PubMed  Google Scholar 

  11. Sobrino-Vegas P, et al. Delayed diagnosis of HIV infection in a multicenter cohort: prevalence, risk factors, response to HAART and impact on mortality. Curr HIV Res. 2009;7(2):224–30.

    Article  CAS  Google Scholar 

  12. Diaz A, et al. Effects of region of birth, educational level and age on late presentation among men who have sex with men newly diagnosed with HIV in a network of STI/HIV counselling and testing clinics in Spain. Euro Surveill. 2015;20(14).

  13. Farnham PG, et al. Updates of lifetime costs of care and quality-of-life estimates for HIV-infected persons in the United States: late versus early diagnosis and entry into care. J Acquir Immune Defic Syndr. 2013;64(2):183–9.

    Article  Google Scholar 

  14. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS. 2006;20(10):1447–50.

    Article  Google Scholar 

  15. Ford N, et al. Getting to zero HIV deaths: progress, challenges and ways forward. J Int AIDS Soc. 2013;16:18927.

    Article  Google Scholar 

  16. Xie J, et al. Delays in HIV diagnosis and associated factors among patients presenting with advanced disease at a tertiary care hospital in Beijing, China. PLoS ONE. 2017;12(8):e0182335.

    Article  Google Scholar 

  17. Desai S, et al. An overview of the HIV epidemic among men who have sex with men in the United Kingdom, 1999–2013. Euro Surveill. 2015. https://0-doi-org.brum.beds.ac.uk/10.2807/1560-7917.ES2015.20.14.21086

    Article  PubMed  Google Scholar 

  18. Dai SY, et al. Prevalence and factors associated with late HIV diagnosis. J Med Virol. 2015;87(6):970–7.

    Article  Google Scholar 

  19. Hu H, et al. Trends in late HIV diagnosis among men who have sex with men in Jiangsu province, China: results from four consecutive community-based surveys, 2011-2014. PLoS ONE. 2017;12(3):e0172664.

    Article  Google Scholar 

  20. Pan X, et al. Characteristics and influencing factors of HIV detection among HIV/AIDS patients in Zhejiang province in 2012. Zhonghua Yu Fang Yi Xue Za Zhi. 2014;48(5):380–5.

    PubMed  Google Scholar 

  21. Tang HL, et al. Analysis on late diagnosis reasons of newly diagnosed HIV/AIDS patients. Zhonghua Yu Fang Yi Xue Za Zhi. 2012;46(11):1004–8.

    PubMed  Google Scholar 

  22. Jiang H, et al. Risk factors for advanced HIV disease and late entry to HIV care: National 1994–2012 HIV Surveillance Data for Wuhan, China. AIDS Patient Care STDS. 2015;29(10):541–9.

    Article  Google Scholar 

  23. Mocroft A, et al. Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). PLoS Med. 2013;10(9):e1001510.

    Article  Google Scholar 

  24. Horino T, et al. Associations of HIV testing and late diagnosis at a Japanese university hospital. Clinics. 2016;71(2):73–7.

    Article  Google Scholar 

  25. Gullon A, et al. Factors associated with late diagnosis of HIV infection and missed opportunities for earlier testing. AIDS Care. 2016;28(10):1296–300.

    Article  Google Scholar 

  26. Chen L, et al. HIV cause-specific deaths, mortality, risk factors, and the combined influence of HAART and late diagnosis in Zhejiang, China, 2006–2013. Sci Rep. 2017;7:42366.

    Article  CAS  Google Scholar 

  27. Cheng W, et al. Late presentation of HIV infection: prevalence, trends, and the role of HIV testing strategies in Guangzhou, China, 2008–2013. Biomed Res Int. 2016;2016:1631878.

    PubMed  PubMed Central  Google Scholar 

  28. Delpech V, et al. Quality of HIV care in the United Kingdom: key indicators for the first 12 months from HIV diagnosis. HIV Med. 2013;14(Suppl 3):19–24.

    Article  Google Scholar 

  29. Shen Y, et al. Analysis of the immunologic status of a newly diagnosed HIV positive population in China. BMC Infect Dis. 2013;13:429.

    Article  Google Scholar 

  30. Branson BM, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55(14):1–17 (quiz CE1-4).

    PubMed  Google Scholar 

  31. Moyer VA, U.S.P.S.T. Force*. Screening for HIV: US preventive services task force recommendation statement. Ann Intern Med. 2013;159(1):51–60.

    Article  Google Scholar 

  32. Jiang H, et al. Gender difference in advanced HIV disease and late presentation according to European consensus definitions. Sci Rep. 2015;5:14543.

    Article  CAS  Google Scholar 

  33. Camara M, et al. Low-level CD4+ T cell activation in HIV-exposed seronegative subjects: influence of gender and condom use. J Infect Dis. 2010;201(6):835–42.

    Article  Google Scholar 

  34. Yombi JC, et al. Late presentation for human immunodeficiency virus HIV diagnosis results of a Belgian single centre. Acta Clin Belg. 2014;69(1):33–9.

    Article  CAS  Google Scholar 

  35. Noble G, et al. Factors associated with late HIV diagnosis in North-East Scotland: a six-year retrospective study. Public Health. 2016;139:36–43.

    Article  CAS  Google Scholar 

  36. Celesia BM, et al. Late presentation of HIV infection: predictors of delayed diagnosis and survival in Eastern Sicily. Eur Rev Med Pharmacol Sci. 2013;17(16):2218–24.

    CAS  PubMed  Google Scholar 

  37. Drain PK, et al. Risk factors for late-stage HIV disease presentation at initial HIV diagnosis in Durban, South Africa. PLoS ONE. 2013;8(1):e55305.

    Article  CAS  Google Scholar 

  38. Mugavero MJ, et al. Late diagnosis of HIV infection: the role of age and sex. Am J Med. 2007;120(4):370–3.

    Article  Google Scholar 

  39. Althoff KN, et al. CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation? AIDS Res Ther. 2010;7:45.

    Article  Google Scholar 

  40. Kwobah CM, et al. Factors associated with late engagement to HIV Care in Western Kenya: a cross-sectional study. J Int Assoc Provid AIDS Care. 2016;15(6):505–11.

    Article  Google Scholar 

  41. Rane MS, et al. Depression and anxiety as risk factors for delayed care-seeking behavior in HIV positive individuals in South Africa. Clin Infect Dis. 2018;67(9):1411–1488.

    Article  Google Scholar 

  42. Heckman TG, et al. Psychological symptoms among persons 50 years of age and older living with HIV disease. Aging Ment Health. 2002;6(2):121–8.

    Article  CAS  Google Scholar 

  43. Op de Coul EL, et al. Factors associated with presenting late or with advanced HIV disease in the Netherlands, 1996–2014: results from a national observational cohort. BMJ Open. 2016;6(1):e009688.

    Article  Google Scholar 

  44. Wilson K, et al. Frequency and correlates of late presentation for HIV infection in France: older adults are a risk group—results from the ANRS-VESPA2 Study, France. AIDS Care. 2014;26(Suppl 1):S83–93.

    Article  Google Scholar 

  45. Camoni L, et al. Late presenters among persons with a new HIV diagnosis in Italy, 2010–2011. BMC Public Health. 2013;13:281.

    Article  Google Scholar 

  46. Girardi E, et al. Delayed presentation and late testing for HIV: demographic and behavioral risk factors in a multicenter study in Italy. J Acquir Immune Defic Syndr. 2004;36(4):951–9.

    Article  Google Scholar 

  47. Vives N, et al. Factors associated with late presentation of HIV infection in Catalonia, Spain. Int J STD AIDS. 2012;23(7):475–80.

    Article  CAS  Google Scholar 

  48. Dukers-Muijrers NH, et al. Effectiveness of an opting-out strategy for HIV testing: evaluation of 4 years of standard HIV testing in a STI clinic. Sex Transm Infect. 2009;85(3):226–30.

    Article  CAS  Google Scholar 

  49. Gallo P, et al. Social and behavioural characteristics of a sample of AIDS Help-Line users never tested for HIV in Italy. Eur J Public Health. 2011;21(5):627–31.

    Article  Google Scholar 

  50. Limb M. Offer regular HIV tests to high risk groups to reduce late diagnoses, says public health agency. BMJ. 2012;345:e8169.

    Article  Google Scholar 

Download references

Authors’ contributions

LY, HL, ZYS, BYL, JJJ, JGH designed the study and provided the correlative knowledge. CXZ, BZ, JL, JZL, RFC, XWP collected and provided the data, including data extraction and data cleaning. XH, CYN, NZ, YYL, PJP, XL, GHL analyzed the data. XH, BYL, CXZ drafted of the manuscript. All authors read and approved the final manuscript.

Acknowledgements

We thank all the physicians and patients who took part in this study.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

The datasets used or analyzed during the current study are available from the corresponding author on reasonable request.

Consent for publication

Not applicable.

Ethics approval and consent to participate

This study was approved by the Ethics and Human Subjects Committee of Guangxi Medical University (Ethical Review No. 20140305-009). Written informed consent was obtained from each participant prior to their enrollment.

Funding

The study was supported by National Natural Science Foundation of China (NSFC, 81560326, 31860040, 81803295, 81860655, and 81660334), Natural Science Foundation of Guangxi Province (2018GXNSFAA138070, 2016GXNSFBA380189, 2018GXNSFAA138002), China Postdoctoral Science Foundation (2018M640890, 2018M643382), Guangxi Science Foundation for Distinguished Young Scholars (2018JJG140004), Guangxi Science Foundation (2018JJA140536), Guangxi University “100-Talent” Program & Guangxi university innovation team and outstanding scholars’ program (Gui Jiao Ren 2014[7]), Key Program of Guangxi Collaborative Innovation Center for Biomedicine (GCICB-SR-2017007), Science Foundation for The Excellent Young Scholars of Guangxi Collaborative Innovation Center for Biomedicine (GCICB-TC-2017015, GCICB-TC-2017004), Innovation Project of Guangxi Graduate Education (YCBZ2018042), National Key Science and Technology Project of China (Grant no. 2018ZX10101002-001-006).

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Author information

Author notes

  1. Xi Hu, Bingyu Liang and Chongxing Zhou contributed equally to this paper

Authors and Affiliations

  1. Guangxi Key Laboratory of AIDS Prevention and Treatment, School of Public Health, Guangxi Medical University, Nanning, 530021, Guangxi, China

    Xi Hu, Bingyu Liang, Junjun Jiang, Jiegang Huang, Chuanyi Ning, Jie Liu, Bo Zhou, Ning Zang, Jinzhen Lai, Rongfeng Chen, Yanyan Liao, Peijiang Pan, Xin Liu, Li Ye & Hao Liang

  2. Guangxi Collaborative Innovation Center for Biomedicine, Life Sciences Institute, Guangxi Medical University, Nanning, 530021, Guangxi, China

    Xi Hu, Bingyu Liang, Junjun Jiang, Jiegang Huang, Chuanyi Ning, Jie Liu, Bo Zhou, Ning Zang, Jinzhen Lai, Rongfeng Chen, Yanyan Liao, Peijiang Pan, Xin Liu, Li Ye & Hao Liang

  3. Institute of HIV/AIDS Prevention and Control, Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention, Nanning, 530200, Guangxi, China

    Chongxing Zhou, Guanghua Lan, Xianwu Pang & Zhiyong Shen

Authors
  1. Xi Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bingyu Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chongxing Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Junjun Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jiegang Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Chuanyi Ning
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jie Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Bo Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ning Zang
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Jinzhen Lai
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Rongfeng Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Yanyan Liao
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Peijiang Pan
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Xin Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Guanghua Lan
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Xianwu Pang
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Li Ye
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Zhiyong Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Hao Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Li Ye, Zhiyong Shen or Hao Liang.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hu, X., Liang, B., Zhou, C. et al. HIV late presentation and advanced HIV disease among patients with newly diagnosed HIV/AIDS in Southwestern China: a large-scale cross-sectional study. AIDS Res Ther 16, 6 (2019). https://0-doi-org.brum.beds.ac.uk/10.1186/s12981-019-0221-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/s12981-019-0221-7

Keywords

AIDS Research and Therapy

ISSN: 1742-6405

Contact us